Thursday, May 30, 2019

Lupin#39;s Goa facility may face regulatory action, says USFDA

Lupin#39;s Goa facility may face regulatory action, says USFDA The company has received a letter from the US Food and Drug Administration (USFDA) classifying the inspection conducted at its Goa facility between January 28 to February 8 as Official Action Indicated (OAI), Lupin said in a regulatory filing.

from Moneycontrol Business News http://bit.ly/2Z0UEHU
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

S&P 500, Nasdaq end higher on Amazon-OpenAI deal; Fed path forward grows murky

Artificial intelligence deals propelled the S&P 500 and Nasdaq higher on Monday, with Amazon's $38 billion agreement with OpenAI and...